Bicara Therapeutics Inc.

BCAX

$20.41▲ 2.05% 24h

Advanced chart & tools →

Bicara Therapeutics Inc.BCAX

$20.41

+$6.52(+46.91%)Past Year

Jun 25Sep 25Dec 25Mar 26Jun 26

Key statistics

Market cap

$1.34B

P/E ratio

—

EPS (diluted)

$-2.52

Dividend yield

0.00%

Dividend / share

$0.00

Revenue

—

Net income

$-137.95M

Net margin

—

Gross margin

—

Dividends & financials

Bicara Therapeutics Inc. (BCAX) reported revenue of — and net income of $-137.95M, or $-2.52 per diluted share. It does not currently pay a dividend. Financial figures are sourced from the company’s latest public filings; the price chart updates live, 24/7, even when the underlying market is closed.